Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 155
Filter
1.
Acta Physiol Hung ; 98(3): 273-83, 2011 Sep.
Article in English | MEDLINE | ID: mdl-21893466

ABSTRACT

UNLABELLED: Hempseed contains a unique combination of both omega-3 and omega-6 polyunsaturated fatty acids. In other studies, supplementation of the diet with selected polyunsaturated fatty acids has induced significant, beneficial cardiovascular effects. The purpose of the present study is to determine if hempseed ingestion over an 8-week period may provide protection to rabbits against the deleterious effects associated with dietary cholesterol supplementation. METHODS: Male albino New Zealand White rabbits were randomly divided into one of six groups: the control diet (RG), the control diet then supplemented with (wt/wt) 5% coconut oil (CO), or 10% hempseed (HP), or 0.5% cholesterol (OL), or with both 10% hempseed and 0.5% cholesterol (OLHP) or with 10% hempseed that was partially delipidated (SC). Each day the rabbits were fed 125 grams of the appropriate diet over an 8-week period. Fatty acid analysis of tissue and diets was determined using gas chromatography. Vascular function testing of aortic rings was done in order to assess the response of the tissue to both contraction and relaxation stimuli. Aortic atherosclerotic plaque was quantified. RESULTS: Cholesterol supplementation to the diet induced significant aortic plaque development. Dietary hempseed did not generate protection. The aorta obtained from rabbits fed the cholesterol-supplemented chow also exhibited defects in their contractile responses to KCl and norepinephrine and in relaxation to sodium nitroprusside (SNP).The addition of hempseed to this diet did not generate any improvement in contractile responses but had a modest protective effect on the cholesterol-induced defects in SNP-induced relaxation. CONCLUSIONS: Our data demonstrate that dietary hempseed provides mildly beneficial effects against contractile dysfunction associated with atherosclerotic vessels in the cholesterol-fed rabbit.


Subject(s)
Aorta, Abdominal/drug effects , Aortic Diseases/drug therapy , Atherosclerosis/drug therapy , Cannabis , Dietary Supplements , Fatty Acids, Unsaturated/administration & dosage , Hypercholesterolemia/drug therapy , Vasoconstriction , Analysis of Variance , Animals , Aorta, Abdominal/pathology , Aorta, Abdominal/physiopathology , Aortic Diseases/blood , Aortic Diseases/etiology , Aortic Diseases/pathology , Aortic Diseases/physiopathology , Atherosclerosis/blood , Atherosclerosis/etiology , Atherosclerosis/pathology , Atherosclerosis/physiopathology , Chromatography, Gas , Disease Models, Animal , Dose-Response Relationship, Drug , Hypercholesterolemia/blood , Hypercholesterolemia/complications , Hypercholesterolemia/physiopathology , Lipids/blood , Male , Rabbits , Seeds , Time Factors , Vasoconstriction/drug effects , Vasoconstrictor Agents/pharmacology , Vasodilation/drug effects , Vasodilator Agents/pharmacology
2.
Prenat Diagn ; 30(5): 418-24, 2010 May.
Article in English | MEDLINE | ID: mdl-20306459

ABSTRACT

OBJECTIVE: To develop a standardized blood collection device that preserves fetal cell-free DNA and minimizes the cell-free DNA background in maternal plasma. METHODS: Blood samples were drawn from healthy pregnant donors into K(3)EDTA (BD vacutainer) and Cell-free DNA BCT tubes (Streck, Inc.) and kept at ambient temperature. Plasma was separated by centrifugation and cell-free DNA was extracted. Cell-free DNA from plasma was quantified by quantitative real-time polymerase chain reaction. RESULTS: Blood drawn into Cell-free DNA BCT tubes showed no change in the original proportion of fetal cell-free DNA during a 14-day storage period at ambient temperature. Conversely, maternal blood drawn into K(3)EDTA tubes showed a steady reduction in the original proportion of fetal cell-free DNA over the same time period. Using maternal plasma stored in Cell-free DNA BCT tubes for 14 days, fetal cell-free DNA was amplified 80-fold using whole genome amplification (WGA). CONCLUSION: Using Streck's Cell-free DNA BCT tubes, it is possible to preserve the original proportion of fetal cell-free DNA for extended times as well as minimize the post-sampling maternal cell-free DNA background. Preserved in this way, fetal cell-free DNA can be amplified by WGA technology to be used in prenatal diagnostic tests.


Subject(s)
Blood Specimen Collection/methods , Chromosomes, Human, Y/genetics , DNA/blood , Maternal-Fetal Exchange/genetics , Blood Specimen Collection/standards , Case-Control Studies , Female , Humans , Polymerase Chain Reaction , Pregnancy , Pregnancy Trimester, First/genetics
3.
Mol Genet Genomics ; 271(6): 752-60, 2004 Jul.
Article in English | MEDLINE | ID: mdl-15221460

ABSTRACT

TATA boxes are the most common regulatory elements found in the promoters of eukaryotic genes because they are associated with basal transcription initiation by RNA polymerase II. Often only a single TATA element is found in a given promoter, and tissue-, stage- and/or stimulus-specific expression occurs because the TATA box is associated with other cis -acting elements that enhance or repress transcription. We used software tools for gene analysis to assist in locating potential TATA box(es) in an AT-rich region of the promoter of a gene, inrpk1, which codes for a leucine-rich receptor protein kinase in morning glory (Ipomoea nil). Through the use of RT-PCR and various combinations of forward primers bracketing most of the promoter region we were able to define the 5'-ends of transcripts in this region. The region was then targeted for analysis by RNA Ligase-Mediated-5' Rapid Amplification of cDNA Ends (RLM-5' RACE) to identify the transcript initiation site(s). Positioning of initiation sites with respect to TATA boxes identified by gene analysis tools allowed us to identify three operational TATA elements which regulate basal transcription from this gene. Two TATA boxes were responsible for all of the inrpk1 transcripts found in leaves and cotyledons, and about 25-30% of the transcripts in roots. A third TATA box was involved only in expression in roots and accounted for the remaining 50-70% of root transcripts. RNAs expressed from this element lack two potentially functional upstream AUG codons, and may be translated more efficiently than transcripts originating from the other TATA boxes.


Subject(s)
Alternative Splicing , Gene Expression Regulation, Enzymologic , Gene Expression Regulation, Plant , Ipomoea/enzymology , Plant Proteins/genetics , Receptor Protein-Tyrosine Kinases/genetics , TATA Box , Base Sequence , Cotyledon/genetics , Cotyledon/metabolism , Ipomoea/genetics , Ipomoea/growth & development , Molecular Sequence Data , Plant Leaves/genetics , Plant Leaves/metabolism , Plant Roots/genetics , Plant Roots/metabolism , Protein Serine-Threonine Kinases , RNA Processing, Post-Transcriptional , RNA, Plant/genetics , Reverse Transcriptase Polymerase Chain Reaction
4.
J Nutr Health Aging ; 7(1): 24-9, 2003.
Article in English | MEDLINE | ID: mdl-12679837

ABSTRACT

Alzheimer's Disease (AD) is a clinical-pathological entity that probably derives from different causes. Mounting evidence strongly implicates regionally increased oxidative damage to brain beyond what occurs with aging as one of the processes that may contribute to AD progression. While several different classes of molecules may be affected, lipid peroxidation is thought to be a prominent and especially deleterious form of oxidative damage in brain due to this organ's relative enrichment in polyunsaturated fatty acids. Our laboratory recently has demonstrated that lipoproteins in AD brain extracellular fluid are more vulnerable to oxidation than lipoproteins in control brain extracellular fluid. Apolipoprotein E (apoE) is the principal apolipoprotein in the central nervous system (CNS), and it serves as the major apolipoprotein that is capable of lipid transport and regulation of lipid metabolism through known receptor-mediated processes. Moreover, inheritance of the APOE4 allele represents the strongest genetic risk factor for sporadic AD. Evidence suggests that apoE isoforms may specifically influence the cellular distribution of lipid peroxidation products in brain and may therefore contribute to the stratification of risk for AD associated with APOE. Here, we review possible mechanisms whereby lipoprotein trafficking and lipid peroxidation converge to contribute to neurodegeneration in AD brain.


Subject(s)
Alzheimer Disease/metabolism , Lipid Peroxidation/physiology , Lipoproteins/metabolism , Aged , Alzheimer Disease/physiopathology , Humans
8.
Nurse Educ Pract ; 1(2): 64-72, 2001 Jun.
Article in English | MEDLINE | ID: mdl-19036246

ABSTRACT

Given that nursing is a practice-based discipline with care and caring at the core, it can be argued that these two elements should be fundamental concepts within the nursing curriculum. With the ever-increasing use of health care technology it is, however, possible that caring theory as an underpinning concept could be omitted from the curriculum. This literature review explores the issues surrounding student nurses' understanding of what care means to them, and considers the process of conveying the meaning and practice of care to the student nurse. Through reviewing the main theme of Education for Care, the question 'Is it possible to teach "care" to students?' will be explored.

9.
Plant Mol Biol ; 43(1): 43-58, 2000 May.
Article in English | MEDLINE | ID: mdl-10949373

ABSTRACT

A gene (inrpk1) encoding a putative receptor-like protein kinase was isolated from the Japanese morning glory, Ipo-moea (Pharbitis) nil Roth. cv. Violet. The receptor-like portion of the largest derived polypeptide contains 26 direct leucine-rich repeats (LRRs) in a single block, and the catalytic portion has all the conserved amino acid residues characteristic of Ser/Thr protein kinases. RNA blot analysis detected multiple transcripts in cotyledons. The largest (4.4 kb) transcript encodes the predicted full length polypeptide (INRPK1), whereas a 1.6 kb transcript apparently originates from a secondary transcription initiation site within the gene and potentially encodes a protein kinase identical to INRPK1 but lacking most of the LRRs. Two transcripts (ca. 2.7 and 2.6 kb) are created by alternative 3'-splicing of a large (ca. 1.4-1.5 kb) cryptic intron in the LRR region, creating one transcript (2.6 kb) potentially encoding a small, secretable polypeptide. The larger transcript encoding a polypeptide identical to INRPK1, but lacking 21 LRRs, predominates in vegetative roots. Competitive PCR indicates that inrpk1 mRNA increases 20-fold in cotyledons in response to a previously given single floral-inducing short-day (SD). No differences of this magnitude were detected in any other organs examined from plants similarly treated. This pattern of expression and differential processing suggests a role for inrpk1 in some aspect of SD photoperiodic-induced flowering in morning glory.


Subject(s)
Alternative Splicing , Plant Proteins/genetics , Plants/genetics , RNA Processing, Post-Transcriptional , Receptor Protein-Tyrosine Kinases/genetics , Amino Acid Sequence , Base Sequence , Blotting, Southern , DNA, Plant/chemistry , DNA, Plant/genetics , DNA, Plant/isolation & purification , Gene Dosage , Gene Expression Regulation, Developmental/radiation effects , Gene Expression Regulation, Enzymologic/radiation effects , Gene Expression Regulation, Plant/radiation effects , Genes, Plant/genetics , Molecular Sequence Data , Photoperiod , Plant Development , Protein Serine-Threonine Kinases , RNA, Messenger/genetics , RNA, Messenger/metabolism , Sequence Analysis, DNA , Tissue Distribution , Transcription, Genetic
10.
Ann Allergy Asthma Immunol ; 85(1): 70-3, 2000 Jul.
Article in English | MEDLINE | ID: mdl-10923608

ABSTRACT

BACKGROUND: Although cystic fibrosis is the most common genetic disorder of children, its heterogeneous spectrum of severity lends itself to underdiagnosis in the older adult patient population where the index of suspicion is not high. METHODS: We report a 60-year-old Hispanic man with asthma who presented with progressive dyspnea and wheezing unresponsive to inhaled corticosteroid treatment. Additionally, he had clinical findings and a past history suggestive of cystic fibrosis. Skin testing, radiography and laboratory studies were completed to evaluate for allergic bronchopulmonary aspergillosis (ABPA) and cystic fibrosis. RESULTS: Test results revealed peripheral eosinophilia and hyper IgE. Skin testing to Aspergillus fumigatus (Af) was positive. IgG, IgM, and Af specific antibodies were present. High resolution CT scan showed central bronchiectasis. Sweat tests were positive on two separate occasions and gene analysis showed our patient to have a positive gene mutation at D127ON/D127ON. CONCLUSION: Cystic fibrosis should be suspected in the older adult patient with a compatible clinical presentation.


Subject(s)
Aspergillosis, Allergic Bronchopulmonary/diagnosis , Cystic Fibrosis/diagnosis , Aspergillosis, Allergic Bronchopulmonary/complications , Asthma/complications , Diagnosis, Differential , Family Health , Humans , Male , Middle Aged , Respiratory Function Tests , Sputum/microbiology
11.
Microsc Res Tech ; 50(4): 282-6, 2000 Aug 15.
Article in English | MEDLINE | ID: mdl-10936881

ABSTRACT

Interest in cerebrospinal fluid (CSF) lipoproteins has been stimulated by the association of certain alleles of the human apolipoprotein E gene (APOE) with an increased risk of Alzheimer's disease (AD), and because apolipoprotein E (apoE) is one of the major apolipoproteins in CSF. CSF lipoproteins (d < 1.210 g/ml fraction) are distinct from their plasma counterparts, and in AD patients CSF may contain novel particles. The protein concentration of CSF lipoproteins is reduced in AD patients. Moreover, the molecular distribution of apoE- and apoAII-containing apolipoproteins in CSF is dictated by APOE. The lipid composition suggests that CSF lipoproteins from AD patients may have undergone increased free radical-mediated damage; experimental data support the possibility that this may occur both before and after lipoprotein assembly. Finally, human CSF lipoproteins oxidized ex vivo are neurotoxic to neuronal cells in culture and disrupt microtubule structure, an activity not observed with oxidized bovine CSF lipoproteins. CSF lipoproteins may represent a means whereby apoE influences the outcome of free radical-mediated damage to brain.


Subject(s)
Alzheimer Disease/cerebrospinal fluid , Lipoproteins/cerebrospinal fluid , Alzheimer Disease/metabolism , Alzheimer Disease/pathology , Apolipoproteins E/cerebrospinal fluid , Apolipoproteins E/metabolism , Brain/metabolism , Brain/pathology , Humans , Lipoproteins/metabolism , Oxidation-Reduction
12.
Ann Allergy Asthma Immunol ; 85(6 Pt 1): 495-500, 2000 Dec.
Article in English | MEDLINE | ID: mdl-11152172

ABSTRACT

BACKGROUND: Inhaled corticosteroids (ICS) have become first line agents in the management of moderate-to-severe asthma. Long-term use of ICS is associated with decreased bone mineral density (BMD). OBJECTIVE: To investigate the prevalence of BMD loss and its severity in women with asthma on long-term ICS. METHODS: Fifty-six women with asthma on long-term ICS, attending an inner-city allergy clinic were selected to undergo bone densitometry in order to evaluate the association between BMD and the long-term use of ICS at different dose ranges. RESULTS: Women (60.7%) had decreased BMD either at the lumbar spine or hip region. Among postmenopausal women, 17.1% of those <65 years and 42.9% of those > or =65 years had osteoporosis compared with 5.7% (95% CI-3.9% to 8.5%) of those <65 and 29.3% (95% CI-25.7%-33.5%) of those > or =65 years reported in the NHANES III survey. The prevalence of low BMD increased as ICS dose increased from 5% in the low dose group to 50% in the high dose group (P < .002). There were significant linear trends of decline by dose in mean BMD for the hip (P < .001) and the lumbar spine (P < .002). Women who received medium or high doses of ICS had significantly greater bone loss than those receiving low doses. CONCLUSION: The findings of increasing BMD loss with increasing ICS dose reinforce the necessity to monitor BMD periodically in women on ICS, particularly in the high risk postmenopausal group and those on medium to high doses. There should be a concurrent continual attempt to lower the dose by supplemental nonsteroidal controller medications and providing nutritional and pharmacologic treatment of identified BMD loss in these patients.


Subject(s)
Adrenal Cortex Hormones/administration & dosage , Adrenal Cortex Hormones/therapeutic use , Asthma/drug therapy , Bone Density/drug effects , Administration, Inhalation , Adult , Asthma/physiopathology , Dose-Response Relationship, Drug , Female , Humans , Middle Aged , Postmenopause/physiology , Premenopause/physiology
16.
Ann Allergy Asthma Immunol ; 84(3): 299-303, 2000 Mar.
Article in English | MEDLINE | ID: mdl-10752913

ABSTRACT

BACKGROUND: Asthma morbidity and mortality continue to increase especially in the inner cities despite medical advances in disease management. OBJECTIVE: To investigate the clinical outcomes of inner city asthma patients treated in an allergy clinic. METHODS: Phase 1 involved random review of medical records of 100 asthma patients treated in an allergy clinic for 2 consecutive years, assessing the frequency of hospitalizations, emergency room visits (ERV) and asthma severity during three periods; 1 year prior to initial visit (year 0) and during the first (year 1) and second (year 2) years of intervention. Phase 2 involved administration of quality of life (QOL) survey to 23 patients volunteered from allergy clinic (group I), and 21 patients volunteered from emergency room (group II), treated by primary care or emergency room physicians during the previous year. RESULTS: The frequency of hospitalizations and ERV significantly declined over time (P < .001) with greatest declines during year 1. Disease severity of all patients significantly declined over time (P < .001); good compliers had significant improvement over poor compliers (P < .023). Quality of life scores were significantly lower for both groups than for the general population; and although the scores were higher in the allergy clinic group than in the non-allergy clinic group, significant differences were achieved only in mental health and social functioning domains. CONCLUSIONS: Patients treated in an allergy clinic demonstrate superior clinical outcomes.


Subject(s)
Asthma/therapy , Urban Health Services , Adult , Asthma/epidemiology , Child , Child, Preschool , Emergency Service, Hospital , Health Surveys , Hospitalization , Humans , New York/epidemiology , Patient Compliance , Quality of Life , Severity of Illness Index , Treatment Outcome
SELECTION OF CITATIONS
SEARCH DETAIL
...